Please Wait...

Therapeutic Expertise

You are here

Our global network of investigator sites is focused on outpatient indications.

Bioclinica's high-performing and high-enrolling sites have demonstrated therapeutic expertise in Alzheimer's, cardiovascular, osteoarthritis, endocrinology, diabetes, vaccines and pain.

Over the past two decades, Bioclinica's Research Network has delivered outstanding results for Phase Ib to Phase IV clinical trials in a multitude of therapeutic areas, including:

Alzheimer's Disease

At Bioclinica, we have worked for decades with patients at every stage of Alzheimer's disease and cognitive impairment.

Our personnel understand the care and management necessary to keep such patients engaged with a clinical trial.

Our facilities have been designed with the size and infrastructure required to conduct large prescreening programs and to execute the protocols of prodromal Alzheimer's disease/mild cognitive impairment clinical trials.

Cardiovascular Diseases

Cardiovascular outcome studies have become a standard part of the development of many therapeutic areas and can involve tens of thousands of patients.

With studies being conducted for medications used to treat diabetes, cholesterol, lipids, hypertension, clot prevention, CHF, and more, the competition for qualified patients is fierce.

Bioclinica is positioned and experienced to recruit patients in the numbers required for cardiovascular outcome studies, and to manage the studies for optimal results.

Endocrinology & Type II Diabetes

With nearly 40 diabetes studies under our belt, Bioclinica is able to find the patients you need – and care for them throughout the course of your study.

We have successfully conducted studies in South America and China for years, and have access to a large pool of qualified patients at the global level, including patients who have only received metformin.


Bioclinica has conducted 32 OA studies, ranging from Phase I to Phase IV.

Over the course of these studies, we have worked with a variety of compounds and routes of administration, including ultrasound-guided intra-articular administration.

Site staff are familiar with multiple OA assessment questionnaires, such as WOMAC, PGA, and PD-Q.


Bioclinica has conducted 34 pain-oriented studies for OA and migraine conditions, ranging from Phase I to Phase IV.

Over the course of these studies, we have worked with a variety of compounds and routes of administration, including ultrasound-guided intra-articular administration.

Site staff are familiar with multiple pain assessment questionnaires, such as WOMAC, PGA, and PD-Q.


The Bioclinica Research Network simplifies the complexity and solves the challenges associated with vaccine clinical trials. Whatever stage your vaccine research is in (Phase I-IV), we can assist you with our global network of established, readily-available investigator sites and our extensive patient recruitment capabilities. With best-in-class SOPs and quality systems in place, you will receive outstanding results and deep insights for your vaccine clinical trials. At Bioclinica, we rise above vaccine recruitment challenges to find the patients you want at the speed you need.


Bioclinica handles a wide range of conditions and diseases, and can provide qualified patients for these areas, plus the management and care necessary for a successful clinical trial.

The Bioclinica Research Network also has extensive capabilities to perform clinical research for the following indications:

Alopecia Insomnia
Asthma Irritable Bowel Syndrome (IBS)
Chronic Constipation Migraine Headaches
Chronic Obstructive Pulmonary Disease (COPD) Obesity
Devices Osteoporosis
Dyslipidemia Restless Legs
Gastrointestinal Disorders Rheumatoid Arthritis
Hypercholesterolemia Smoking Cessation

>15,000 Patients Randomized in the Last 5 Years


Research Network

Download Brochure

Alzheimer's Disease

Download Info Sheet

Cardiovascular Outcome Studies

Download Info Sheet


Download Info Sheet

Vaccine Development

Download Info Sheet


Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our #Alzheimers expert's work will B showcased at #ADPD2017 Preview here @adpdnet
bioclinica (Yesterday)
#FunFriday ! A long time ago in a lab far far away....
bioclinica (2 days ago)
Smiles all around on Pizza Day today for @bioclinica eHealth in Audubon compliments of our CTO Andrew Masters. This…
bioclinica (2 days ago)
Missed Tuesday's webinar on agile #IRT? No worries! Catch it here > #Pharma #CRO #eClinical
bioclinica (2 days ago)
RT @ACROhealth: Where do you stand on regulating #mHealth & #Wearables in #clinicalresearch? w/ @bioclinica, @ICONplc, @INC_Research https:…
bioclinica (4 days ago)
RT @ACROhealth: ICYMI: @CCTAwareness’ Infographic on #clinicaltrials awareness for #Alzheimer’s and Parkinson’s treatments.…
bioclinica (4 days ago)

Latest Blogs: